Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2025)

Scinai Immunotherapeutics has disclosed Current Leases across 7 years of filings, most recently posting $329000.0 for Q4 2025.

• Current Leases for Q4 2025 came in at $329000.0, down 22.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $329000.0 (down 22.41% YoY), and the FY2025 annual result was $329000.0, down 22.41% from the prior year.
• Current Leases came in at $329000.0 for Q4 2025 at Scinai Immunotherapeutics, down from $424000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $424000.0 in Q4 2024 to a low of $249000.0 in Q4 2021.
• The 5-year median for Current Leases is $382000.0 (2022), against an average of $356000.0.
• Across the five-year window, Current Leases soared 53.41% in 2022 and retreated 22.41% in 2025, its largest moves.
• Scinai Immunotherapeutics' Current Leases stood at $249000.0 in 2021, then jumped by 53.41% to $382000.0 in 2022, then climbed by 3.66% to $396000.0 in 2023, then climbed by 7.07% to $424000.0 in 2024, then retreated by 22.41% to $329000.0 in 2025.
• The last three Current Leases figures came in at $329000.0 (Q4 2025), $424000.0 (Q4 2024), and $396000.0 (Q4 2023), per Business Quant data.